•
Mar 31, 2016

Jazz Pharmaceuticals Q1 2016 Earnings Report

Total Revenue
$336M
Previous year: $309M
+8.6%
EPS
$2.26
Previous year: $1.99
+13.6%
Gross Profit
$313M
Previous year: $281M
+11.2%
Cash and Equivalents
$980M
Previous year: $783M
+25.2%
Total Assets
$3.53B
Previous year: $3.24B
+9.2%

Jazz Pharmaceuticals

Jazz Pharmaceuticals